chr10-98459584-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_021828.5(HPSE2):c.1769G>A(p.Arg590His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000836 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R590S) has been classified as Uncertain significance.
Frequency
Consequence
NM_021828.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HPSE2 | NM_021828.5 | c.1769G>A | p.Arg590His | missense_variant | 12/12 | ENST00000370552.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HPSE2 | ENST00000370552.8 | c.1769G>A | p.Arg590His | missense_variant | 12/12 | 1 | NM_021828.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000956 AC: 24AN: 251122Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135840
GnomAD4 exome AF: 0.0000746 AC: 109AN: 1461868Hom.: 0 Cov.: 46 AF XY: 0.0000798 AC XY: 58AN XY: 727236
GnomAD4 genome AF: 0.000171 AC: 26AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74424
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2022 | The c.1769G>A (p.R590H) alteration is located in exon 12 (coding exon 12) of the HPSE2 gene. This alteration results from a G to A substitution at nucleotide position 1769, causing the arginine (R) at amino acid position 590 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 21, 2022 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 590 of the HPSE2 protein (p.Arg590His). This variant is present in population databases (rs138098027, gnomAD 0.07%). This missense change has been observed in individual(s) with HPSE2-related conditions (PMID: 25145936). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at